What they were paid
ALNYLAM PHARMACEUTICALS Director Compensation Table · all 3 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $45,920 | $0 | $0 | $7,010 | $52,930 |
| FY2022 | $80,000 | $0 | $399,380 | $15,000 | $494,380 |
| FY2021 | $67,917 | $0 | $399,952 | $25,000 | $492,869 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ALNYLAM PHARMACEUTICALS, INC. DEF 14A filed April 6, 2026, accession 0001628280-26-023923, and prior-year filings. Open the filing on EDGAR.
How this page was built: the ALNYLAM PHARMACEUTICALS, INC. filed document, accession 0001628280-26-023923. Every figure is read from that document and cited to the page and table it appears in. Filed April 6, 2026.
Get the ALNYLAM PHARMACEUTICALS Board Governance Report
$52,930 Phillip A. Sharp, Ph.D, FY2025 total director compensation
$500
The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.
Data as of April 6, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
How this board is paid
company policy · FY2025ALNYLAM PHARMACEUTICALS pays directors a $60,000 cash retainer and $400,000 in 50% Stock Options, 50% RSUs.
Committees
FY2025 · as the proxy prints themScience and Technology
The rest of the ALNYLAM PHARMACEUTICALS board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Amy W. Schulman | Chair of the Board | $541,310 |
| Colleen F. Reitan | Independent Director | $492,350 |
| David E.I. Pyott | Independent Director | $479,850 |
| Dennis A. Ausiello, M.D | Independent Director | $479,850 |
| Elliott Sigal, M.D., Ph.D | Independent Director | $486,310 |
| Margaret A. Hamburg, M.D | Independent Director | $469,850 |
| Olivier Brandicourt, M.D | Independent Director | $482,350 |
| Peter N. Kellogg | Independent Director | $484,850 |
| Stuart A. Arbuckle | Independent Director | — |
| Yvonne L. Greenstreet, M.D | Director | — |
The full ALNYLAM PHARMACEUTICALS compensation record
free company briefThis page is one director within ALNYLAM PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.
Peer companies
named in the ALNYLAM PHARMACEUTICALS proxy · each links to its own free briefOrder ALNY
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.